Ctac N.V. (LON:0E2F)
3.160
-0.220 (-6.51%)
At close: Nov 26, 2025
Ctac N.V. Revenue
Ctac N.V. had revenue of 62.79M EUR in the half year ending June 30, 2025, a decrease of -3.28%. This brings the company's revenue in the last twelve months to 125.22M, up 0.81% year-over-year. In the year 2024, Ctac N.V. had annual revenue of 124.33M, down -2.28%.
Revenue (ttm)
125.22M EUR
Revenue Growth
+0.81%
P/S Ratio
0.37
Revenue / Employee
368.29K EUR
Employees
340
Market Cap
40.17M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 124.33M | -2.90M | -2.28% |
| Dec 31, 2023 | 127.23M | 9.56M | 8.12% |
| Dec 31, 2022 | 117.67M | 11.25M | 10.57% |
| Dec 31, 2021 | 106.42M | 19.12M | 21.90% |
| Dec 31, 2020 | 87.31M | 6.08M | 7.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |